Skip to main content
Erschienen in: Breast Cancer 3/2017

18.08.2016 | Original Article

Genetic polymorphisms in APE1 Asp148Glu(rs3136820) as a modifier of the background levels of abasic sites in human leukocytes derived from breast cancer patients and controls

verfasst von: Wei-Chung Hsieh, Che Lin, Dar-Ren Chen, Wen-Fa Yu, Guan-Jie Chen, Suh-Woan Hu, Chin-Chen Liu, Mao-Huei Ge, Chang-Sin Ruan, Cheng-You Chen, Chia-Hua Lin, Po-Hsiung Lin

Erschienen in: Breast Cancer | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Apurinic/apyrimidinic (abasic/AP) sites are among the most common endogenous DNA lesions. AP sites, if not repaired, could result in genomic instability as well as chromosome aberrations. Information regarding the direct assay of the number of abasic sites in human leukocytes and its association with risk of breast cancer has not been reported.

Methods

In this study, we investigated the association between certain risk factors for breast cancer and the background levels of AP sites in leukocytes derived from 148 Taiwanese women with breast cancer and 140 cancer-free controls. The risk factors studied include age, body mass index (BMI), and polymorphisms of apurinic/apyrimidinic endonuclease (APE1) [APE1 Asp148Glu(rs3136820)].

Results

Mean levels of AP sites were estimated to be 23.3 and 50.3 per 106 nucleotides in controls and breast cancer patients, respectively (~twofold, p < 0.001). In subjects with age <50 or BMI < 27 (kg/m2), the levels of AP sites in breast cancer patients were ~2–3-fold greater than those of controls (p < 0.05). Additionally, results from the AP site 3′-cleavage assay indicated that the AP sites detected in both controls and patients were likely to be oxidant-mediated 5′-cleaved AP sites (~61–64 %). The number of AP sites in breast cancer patients was ~twofold greater in subjects with Asp/Glu + Glu/Glugenotypes than those with Asp/Asp genotype (p < 0.001).

Conclusions

We confirmed that cumulative body burden of AP sites is a significant predictor of the risk of developing breast cancer and that genetic predisposition and environment factors may modulate the induction of oxidative DNA lesions in breast cancer patients.
Literatur
1.
Zurück zum Zitat Swenberg J, et al. Quantitation of cisplatin 1,2-intrastrand guanine-guanine adducts. Chem Res Toxicol. 2010;23(1):289–90. Swenberg J, et al. Quantitation of cisplatin 1,2-intrastrand guanine-guanine adducts. Chem Res Toxicol. 2010;23(1):289–90.
2.
Zurück zum Zitat Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med. 1995;18(6):1033–77.CrossRefPubMed Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med. 1995;18(6):1033–77.CrossRefPubMed
3.
Zurück zum Zitat Nakamura J, Swenberg JA. Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res. 1999;59(11):2522–6.PubMed Nakamura J, Swenberg JA. Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res. 1999;59(11):2522–6.PubMed
4.
Zurück zum Zitat Schaaper RM, Kunkel TA, Loeb LA. Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc Natl Acad Sci USA. 1983;80(2):487–91.CrossRefPubMedPubMedCentral Schaaper RM, Kunkel TA, Loeb LA. Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc Natl Acad Sci USA. 1983;80(2):487–91.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Wilstermann AM, Osheroff N. Base excision repair intermediates as topoisomerase II poisons. J Biol Chem. 2001;276(49):46290–6.CrossRefPubMed Wilstermann AM, Osheroff N. Base excision repair intermediates as topoisomerase II poisons. J Biol Chem. 2001;276(49):46290–6.CrossRefPubMed
6.
Zurück zum Zitat Cavalieri EL, et al. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis. 2002;23(6):1071–7.CrossRefPubMed Cavalieri EL, et al. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis. 2002;23(6):1071–7.CrossRefPubMed
7.
Zurück zum Zitat Convert O, et al. Reactions of estradiol-2,3-quinone with deoxyribonucleosides: possible insights in the reactivity of estrogen quinones with DNA. Chem Res Toxicol. 2002;15(5):754–64.CrossRefPubMed Convert O, et al. Reactions of estradiol-2,3-quinone with deoxyribonucleosides: possible insights in the reactivity of estrogen quinones with DNA. Chem Res Toxicol. 2002;15(5):754–64.CrossRefPubMed
8.
Zurück zum Zitat Lin PH, et al. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA. Carcinogenesis. 2003;24(6):1133–41.CrossRefPubMed Lin PH, et al. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA. Carcinogenesis. 2003;24(6):1133–41.CrossRefPubMed
9.
Zurück zum Zitat Sangrajrang S, et al. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat. 2008;111(2):279–88.CrossRefPubMed Sangrajrang S, et al. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat. 2008;111(2):279–88.CrossRefPubMed
10.
11.
Zurück zum Zitat Lin C, et al. Hemoglobin adducts as biomarkers of estrogen homeostasis: elevation of estrogenquinones as a risk factor for developing breast cancer in Taiwanese Women. Toxicol Lett. 2014;225(3):386–91.CrossRefPubMed Lin C, et al. Hemoglobin adducts as biomarkers of estrogen homeostasis: elevation of estrogenquinones as a risk factor for developing breast cancer in Taiwanese Women. Toxicol Lett. 2014;225(3):386–91.CrossRefPubMed
12.
Zurück zum Zitat Lin C, et al. Investigation of the cumulative body burden of estrogen-3,4-quinone in breast cancer patients and controls using albumin adducts as biomarkers. Toxicol Lett. 2013;218(3):194–9.CrossRefPubMed Lin C, et al. Investigation of the cumulative body burden of estrogen-3,4-quinone in breast cancer patients and controls using albumin adducts as biomarkers. Toxicol Lett. 2013;218(3):194–9.CrossRefPubMed
13.
Zurück zum Zitat Nakamura J, et al. Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res. 1998;58(2):222–5.PubMed Nakamura J, et al. Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res. 1998;58(2):222–5.PubMed
14.
Zurück zum Zitat Popanda O, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25(12):2433–41.CrossRefPubMed Popanda O, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25(12):2433–41.CrossRefPubMed
15.
Zurück zum Zitat Nakajima M, et al. 8-Hydroxydeoxyguanosine in human leukocyte DNA and daily health practice factors: effects of individual alcohol sensitivity. Environ Health Perspect. 1996;104(12):1336–8.CrossRefPubMedPubMedCentral Nakajima M, et al. 8-Hydroxydeoxyguanosine in human leukocyte DNA and daily health practice factors: effects of individual alcohol sensitivity. Environ Health Perspect. 1996;104(12):1336–8.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat van den Brandt PA, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–27.CrossRefPubMed van den Brandt PA, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–27.CrossRefPubMed
17.
Zurück zum Zitat Key TJ, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95(16):1218–26.CrossRefPubMed Key TJ, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95(16):1218–26.CrossRefPubMed
18.
Zurück zum Zitat Haffner SM, et al. Relationship of sex hormone binding globulin to overall adiposity and body fat distribution in a biethnic population. Int J Obes. 1989;13(1):1–9.PubMed Haffner SM, et al. Relationship of sex hormone binding globulin to overall adiposity and body fat distribution in a biethnic population. Int J Obes. 1989;13(1):1–9.PubMed
19.
Zurück zum Zitat Kirschner MA, et al. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab. 1990;70(2):473–9.CrossRefPubMed Kirschner MA, et al. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab. 1990;70(2):473–9.CrossRefPubMed
20.
Zurück zum Zitat Balasubramanian B, Pogozelski WK, Tullius TD. DNA strand breaking by the hydroxyl radical is governed by the accessible surface areas of the hydrogen atoms of the DNA backbone. Proc Natl Acad Sci USA. 1998;95(17):9738–43.CrossRefPubMedPubMedCentral Balasubramanian B, Pogozelski WK, Tullius TD. DNA strand breaking by the hydroxyl radical is governed by the accessible surface areas of the hydrogen atoms of the DNA backbone. Proc Natl Acad Sci USA. 1998;95(17):9738–43.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Nakamura J, La DK, Swenberg JA. 5′-nicked apurinic/apyrimidinic sites are resistant to beta-elimination by beta-polymerase and are persistent in human cultured cells after oxidative stress. J Biol Chem. 2000;275(8):5323–8.CrossRefPubMed Nakamura J, La DK, Swenberg JA. 5′-nicked apurinic/apyrimidinic sites are resistant to beta-elimination by beta-polymerase and are persistent in human cultured cells after oxidative stress. J Biol Chem. 2000;275(8):5323–8.CrossRefPubMed
22.
23.
Zurück zum Zitat Vodicka P, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 2007;28(3):657–64.CrossRefPubMed Vodicka P, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 2007;28(3):657–64.CrossRefPubMed
Metadaten
Titel
Genetic polymorphisms in APE1 Asp148Glu(rs3136820) as a modifier of the background levels of abasic sites in human leukocytes derived from breast cancer patients and controls
verfasst von
Wei-Chung Hsieh
Che Lin
Dar-Ren Chen
Wen-Fa Yu
Guan-Jie Chen
Suh-Woan Hu
Chin-Chen Liu
Mao-Huei Ge
Chang-Sin Ruan
Cheng-You Chen
Chia-Hua Lin
Po-Hsiung Lin
Publikationsdatum
18.08.2016
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 3/2017
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-016-0719-y

Weitere Artikel der Ausgabe 3/2017

Breast Cancer 3/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.